Onderneming Lotus Pharmaceutical Co., Ltd. Taipei Exchange
Aandelen
1795
TW0001795003
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
108 TWD | +0,47% | -4,42% | -.--% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
99,4
%
| 14 503 | 99,1 % | 16 864 | 99,4 % | +16,28% |
Other
0,6
%
| 130 | 0,9 % | 94 | 0,6 % | -27,72% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
40,2
%
| 5 916 | 40,4 % | 6 815 | 40,2 % | +15,18% |
South Korea
32,9
%
| 5 277 | 36,1 % | 5 587 | 32,9 % | +5,86% |
Taiwan
14,2
%
| 0 | 0,0 % | 2 413 | 14,2 % | - |
Others
12,6
%
| 3 439 | 23,5 % | 2 144 | 12,6 % | -37,66% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 29-09-14 | |
I ling Tian
DFI | Director of Finance/CFO | - | 01-11-16 |
Ying Ming Yue
COO | Chief Operating Officer | - | 01-12-22 |
Gwen Hsieh
CIO | Chief Investment Officer | - | 02-08-21 |
Manisha Chawla
CTO | Chief Tech/Sci/R&D Officer | - | 08-07-19 |
Edin Buljubašic
CMP | Compliance Officer | - | 01-12-22 |
Erica Yen
IRC | Investor Relations Contact | - | - |
Bjartur Shen
IRO | Public Communications Contact | - | 16-01-18 |
Ryan Koh
AUD | Comptroller/Controller/Auditor | - | 10-11-22 |
Prashant Godse
PRN | Corporate Officer/Principal | - | 01-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 54 | 23-04-15 |
Director/Board Member | 60 | 11-08-14 | |
Director/Board Member | 61 | 23-04-15 | |
Árni Harðarson
BRD | Director/Board Member | 57 | 11-08-14 |
Chief Executive Officer | - | 29-09-14 | |
Mu Yao Ku
BRD | Director/Board Member | - | 29-09-14 |
Director/Board Member | 59 | - | |
Yves Hermes
BRD | Director/Board Member | - | 30-06-22 |
Director/Board Member | - | 30-06-22 | |
Director/Board Member | - | 23-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 264 958 300 | 128 414 312 ( 48,47 %) | 490 000 ( 0,1849 %) | 48,47 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
FUJI PHARMA CO., LTD. 4.92% | 1 219 000 | 4.92% | 12 316 654 $ |
Bedrijfsgegevens
Lotus Pharmaceutical Co., Ltd.
No. 277, Song Ren Road 17/F, Xin Yi District
110 58, Taipei
+
http://www.lotuspharm.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,21% | 723 mld. | |
+32,22% | 598 mld. | |
-1,94% | 364 mld. | |
+20,29% | 331 mld. | |
+3,69% | 288 mld. | |
+16,60% | 244 mld. | |
+9,77% | 210 mld. | |
-5,15% | 208 mld. | |
+8,75% | 169 mld. |
- Beurs
- Aandelen
- Koers 1795
- Koers 1795
- Onderneming Lotus Pharmaceutical Co., Ltd.